| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2024―Apr―05 |
Alpha-1 adrenergic antagonists and the risk of hospitalization or death in non-hospitalized patients with COVID-19: A population-based study |
Tony Antoniou, Daniel McCormack, Mina Tadrous, Tara Gomes |
| 2 |
[GO] |
2024―Feb―12 |
Population pharmacokinetics and pharmacodynamics of nirmatrelvir in Chinese patients with COVID-19 |
Liyan Zeng, Rui Chen, Xuhua Jiang, Feng Li, Zhaoqin Zhu, Zheng Jiao, et al. (+2) Yun Ling, Lijun Zhang |
| 3 |
[GO] |
2023―Nov―21 |
An exploratory study of drug concentration and inhibitory effect of cetylpyridinium chloride buccal tablets on SARS-CoV-2 infection among 10 Chinese subjects |
Yanting Li, Zhenwei Xie, Liming Chen, Xiangxing Liu, Shuang Li, Shichun Ye, et al. (+13) Hongyan Tang, Chongyou Lee, Qun Gu, Fang Men, Jiaojiao Zhang, Dingyuan Hu, Yuanli Jiang, Xiaochun Wang, Qian Wang, Yufei Feng, Suping Niu, Yan Liu, Yi Fang |
| 4 |
[GO] |
2023―Nov―11 |
Alterations in the gene expression of SARS-COV-2 entry receptors and enzymes in lungs and hearts of controlled and uncontrolled diabetic mice |
Ohood Alkhawaldeh, Yazun Jarrar, Munir Gharaibeh, Sara Abudahab, Dina Abulebdah, Bashir Jarrar |
| 5 |
[GO] |
2023―Jul―20 |
Vestibular disorders following BNT162b2 mRNA COVID-19 vaccination: A retrospective case series |
Helmi Ammar, Christine Le Beller, Didier Bouccara, David Malinvaud, Romain Jouffroy, Agnès Lillo-Le Louet |
| 6 |
[GO] |
2023―May―11 |
Treatment implications of augmented renal clearance in a critically ill COVID-19 patient: a case report |
Susan Deenen, Laura F. C. Fransen, Tessa C. C. Jaspers, Jessica D. Workum |
| 7 |
[GO] |
2023―Mar―18 |
Viral target- and metabolism-based rationale for combined use of recently authorized small molecule COVID-19 medicines: molnupiravir, nirmatrelvir and remdesivir |
Daisy Yan, Bingfang Yan |
| 8 |
[GO] |
2022―May―14 |
Melatonin as a complementary and prophylactic agent against COVID-19 in high-risk populations: A narrative review of recent findings from clinical and preclinical studies |
Abdolkarim Hosseini, Taleb Badri, Hadi Esmaeili Gouvarchin Ghaleh, Kazem Hassanpour, Gholam Hossein Alishiri, Mostafa Akbariqomi, Gholamreza Farnoosh |
| 9 |
[GO] |
2022―May―09 |
Safety profile of hydroxychloroquine used off-label for the treatment of patients with COVID-19: A descriptive study based on Eudravigilance data |
Domenico Motola, Giulia Bonaldo, Nicola Montanaro |
| 10 |
[GO] |
2022―May―03 |
NVX-Cov2373 Novavax Covid-19 vaccine: a further analysis of its efficacy using multiple modes of expression |
Jean-Louis Montastruc, Pierre Biron, Agnès Sommet |
| 11 |
[GO] |
2021―Jul―16 |
In vitro
inhibition and molecular docking of a new ciprofloxacin chalcone against SARS-CoV-2 main protease |
Rania Alaaeldin, Muhamad Mustafa, Gamal El-Din A. Abuo-Rahma, Moustafa Fathy |
| 12 |
[GO] |
2021―Jul―12 |
Efficacy of Covid-19 vaccines: several modes of expression should be presented in scientific publications |
Jean-Louis Montastruc, Pierre Biron, Agnès Sommet |
| 13 |
[GO] |
2021―May―11 |
COVID-19 in DMARD-treated patients with inflammatory rheumatic diseases: Insights from an analysis of the World Health Organization pharmacovigilance database |
Amandine Dernoncourt, Jean Schmidt, Pierre Duhaut, Sophie Liabeuf, Valérie Gras-Champel, Kamel Masmoudi, et al. (+2) Youssef Bennis, Benjamin Batteux |
| 14 |
[GO] |
2021―Apr―20 |
Chronic use of Renin-Angiotensin-Aldosterone-System blockers and mortality in COVID-19: a multicenter prospective cohort and literature review |
Nathalie Gault, Marina Esposito-Farese, Matthieu Revest, Jocelyn Inamo, André Cabie, Élisabeth Polard, et al. (+16) Jean-Sébastien Hulot, Jade Ghosn, Catherine Chirouze, Laurène Deconinck, Jean-Luc Diehl, Julien Poissy, Olivier Epaulard, Benjamin Lefèvre, Lionel Piroth, Etienne de Montmollin, Eric Oziol, Manuel Etienne, Cédric Laouenan, Patrick Rossignol, Dominique Costagliola, Emmanuelle Vidal-Petiot |
| 15 |
[GO] |
2021―Jan―15 |
A systematic review of experimental evidence for antiviral effects of ivermectin and an in-silico analysis of ivermectin's possible mode of action against SARS-CoV-2 |
Robert T. Kinobe, Leigh Owens |
| 16 |
[GO] |
2020―Dec―09 |
Outcome of patients hospitalized for Covid-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: Results of the ACECoV study |
Joachim Alexandre, Jean-Luc Cracowski |
| 17 |
[GO] |
2020―Oct―28 |
Outcome of patients hospitalized for COVID-19 and exposure to angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers in France: results of the ACE-CoV study |
Margaux Lafaurie, Guillaume Martin-Blondel, Pierre Delobel, Sandrine Charpentier, Agnès Sommet, Guillaume Moulis |
| 18 |
[GO] |
2020―Jul―13 |
Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin |
Hakan Parlakpinar, Seyhan Polat, Hacı Ahmet Acet |
| 19 |
[GO] |
2020―Jul―02 |
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments |
Nicolas Venisse |
| 20 |
[GO] |
2020―Jun―30 |
Potential drug-drug interactions associated with drugs currently proposed for COVID-19 treatment in patients receiving other treatments |
Florian Lemaitre, Caroline Solas, Matthieu Grégoire, Laurence Lagarce, Laure Elens, Elisabeth Polard, et al. (+4) Béatrice Saint-Salvi, Agnès Sommet, Michel Tod, Chantal Barin-Le Guellec |
| 21 |
[GO] |
2020―May―12 |
Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic |
Louis Larrouquere, Manon Gabin, Emmanuelle Poingt, Amelle Mouffak, Alex Hlavaty, Marion Lepelley, et al. (+17) Charles Khouri, Alexandre Bellier, Joachim Alexandre, Pierrick Bedouch, Laurent Bertoletti, Regis Bordet, Béatrice Bouhanick, Annie-Pierre Jonville-Bera, Silvy Laporte, Claire Le Jeunne, Louis Letinier, Joëlle Micallef, Florian Naudet, Matthieu Roustit, Mathieu Molimard, Vincent Richard, Jean-Luc Cracowski |
|
